CTRI/2018/03/012508
Recruiting
N/A
Prospective Validation of Prediction algorithms for Preeclampsia in the first, second and third Trimesters of pregnancy
iona Chiu Yee Poon0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- iona Chiu Yee Poon
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •singleton pregnancy with live fetus
- •those who sign the Informed Consent Form
Exclusion Criteria
- •multiple pregnancy, non viable fetus and not signing the consent form
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Development and validation of prediction models for treatment failure of HFNC in COVID-19: a multicenter cohort studyCOVID-19JPRN-UMIN000050024Tohoku University300
Completed
N/A
Prospective validation of a predictive model for pathologic complete response after chemoradiotherapy in rectal cancer: A prognostic studycancer of the rectum/rectumcancer1000211210017991NL-OMON33076MAASTRO clinic60
Completed
N/A
Validating Artificial Intelligence Predictions of Postoperative Delirium after Cardiac SurgeryPostoperative DeliriumF05.0Delirium not superimposed on dementia, so describedDRKS00028749Institut für Anästhesiologie und SchmerztherapieHerz- und Diabeteszentrum NRW393
Completed
N/A
Prospective study of evaluation to the predictive biomarker of Nivolumab by tumor tissue specimen and neighboring bronchoaveolar lavage fluid (BALF) and BloodJPRN-UMIN000023822Respiratory Medicine, Allergy and Rheumatic Diseases Osaka University Graduate School of Medicine20
Active, Not Recruiting
Phase 1
Assessment of a predictive response model for romiplostim in patients with low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE-trialPatients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopeniaMedDRA version: 18.1Level: LLTClassification code 10068361Term: MDSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2013-004328-12-FRGMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH90